CVA Family Office’s Rayonier RYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-20
Closed -$504 – 1355
2025
Q3
$504 Buy
+20
New +$480 ﹤0.01% 1246
2025
Q2
– Sell
-125
Closed -$3.32K – 1426
2025
Q1
$3.32K Buy
125
+23
+23% +$583 ﹤0.01% 947
2024
Q4
$2.53K Sell
102
-5
-5% -$139 ﹤0.01% 955
2024
Q3
$3.12K Hold
107
– – ﹤0.01% 919
2024
Q2
$2.82K Hold
107
– – ﹤0.01% 909
2024
Q1
$3.22K Hold
107
– – ﹤0.01% 880
2023
Q4
$3.24K Buy
+107
New +$2.86K ﹤0.01% 857
2023
Q3
– Sell
-107
Closed -$3.05K – 801
2023
Q2
$3.05K Buy
+107
New +$2.98K ﹤0.01% 855

Other funds holding RYN

CVA Family Office's RYN Position: Q4 2025 in Review

CVA Family Office sold out of Rayonier (RYN) in Q4 2025, closing a stake of 20 shares — an estimated $504 sold.

CVA Family Office first reported a position in RYN in Q2 2023 and held it in 8 quarters. The position peaked at $3.32K in Q1 2025. 360 funds tracked by Wall St. Rank hold RYN as of Q4 2025.

  • CVA Family Office reported no remaining Rayonier position as of Q4 2025 after selling out during the quarter.
  • CVA Family Office sold 20 Rayonier shares in Q4 2025, an estimated $504.
  • CVA Family Office first reported a position in Rayonier in Q2 2023 and held it in 8 quarters.
  • CVA Family Office's Rayonier position peaked at $3.32K in Q1 2025.
  • 360 funds tracked by Wall St. Rank held Rayonier as of Q4 2025.

Based on CVA Family Office's 13F filing for Q4 2025, filed 12 Jan 2026.